In this report, we quantify the impact of these dynamics and examine the spending and usage of medicines in 2023 and the outlook to 2028, globally and for specific therapy areas and countries. Market players compete based on factors such as product quality, pricing, supply chain efficiency, regulatory compliance, and market reach. Additionally, expanding into emerging markets, both domestically and internationally, can help diversify the customer base and reduce reliance on saturated markets.
For example, Ecuador has absorbed up to 300,000 refugees from Colombia who are running from guerrillas, paramilitaries and drug lords. The countries of drug production and transit are some of the most affected by the trade, though countries receiving the illegally imported substances are also adversely affected. This gave the United States military broad authority to employ military force against drug cartels and to target their leaders through direct military action. In 2025, by executive order, the United States expanded its approach in its counter drug campaign to designate foreign drug cartels as foreign terrorist organizations.
- The global prescription drugs market size is projected to grow from $1,240.33 billion in 2024 to $2,151.63 billion by 2032, at a CAGR of 7.1%
- Hospital pharmacies contain all the medicines that are prescribed by healthcare professionals.
- The demand for generics increases as payers and consumers seek ways to cut healthcare costs.
- The IRA’s “pill penalty” also makes small-molecule drugs subject to negotiation sooner than biologics, which may reduce R&D in that area and shrink the future pipeline of traditional generics.17
- Janssen's new drug design system will enhance the process of discovering new medications by accelerating the identification of molecules.
What Is The Pharmaceutical Market Growth?
Generic pharmaceuticals are drug products that contain the same active ingredients of the same strength as that of their brand drugs. Oncology generics top growth charts with a 9.21% CAGR, buoyed by biosimilar launches for high-cost monoclonal antibodies. A top-down model rebuilt global generic spending by applying molecule-level patent expiry schedules to branded drug sales, adjusting for typical penetration and price-decline patterns, and then allocating by therapy, route, and region. Nevertheless, inflation-linked input costs and upcoming price negotiation clauses will test profitability, pressuring companies to automate quality control, diversify suppliers, and optimize route-to-market economics.
Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2025
Beyond its role in developing innovative medicines that enhance health and quality of life globally, it stands as one of the continent’s strongest high-technology sectors. The research-based pharmaceutical industry is one of Europe’s most valuable economic and scientific assets. This surge is boosting production and fueling research and development efforts, supported by both government funding and corporate investments. India sells pharmaceuticals to more than 200 nations, making it a major exporter. The region's growing number of medicinal approvals is another important element supporting the market's expansion.
Regionalisation Of Production Based On Precursors
Colombia served as the dominant force in the distribution and sale of cocaine by the 1980s. The business of drug trafficking can be seen in several stages in Colombia towards the latter half of the 20th century. Instead, drug traffickers in Colombia continued their focus on exporting cocaine.
Global Generic Drugs Market Trends And Insights
Hence, biosimilars are widely preferred in such cases as they reduce the cost by one-third than that of their biologic counterparts. The development and manufacturing processes are, in most cases, straightforward. However, small molecule generics do not undergo such complex approval steps.
Food and Drug Administration (FDA), require generic drugs to demonstrate bioequivalence to the branded drugs they are intended to replace. Price often becomes the primary factor in purchasing decisions, leading to a commoditization of generic drugs. These generics are affordable alternatives to brand-name drugs and have significantly contributed to reducing healthcare expenses. These programs aim to increase competition, reduce drug prices, and enhance the availability of generic drugs to patients.
Funding also facilitates market research and marketing activities to create awareness and promote the use of generic medications. This cost advantage makes them more accessible to patients and contributes to significant cost savings for healthcare systems and insurance providers. In addition, Off-patent, off-exclusivity drugs are typically priced lower than their brand-name counterparts.
By Route Of Administration
The Asia Pacific region, however, is anticipated to witness the highest growth rate, driven by its large population base, increasing healthcare access, and expanding middle-class segment willing to spend more on healthcare. Specialty drugs are typically used to treat chronic, complex, or rare conditions, necessitating a distribution network that ensures their safe and efficient delivery to patients. Specialty Drug Distribution plays a pivotal role in the pharmaceutical supply chain, particularly in the context of the retail drug market's expansion. The increasing consumer awareness and education about pharmaceutical products also play a pivotal role in the market's growth. Additionally, the rise of telemedicine and online pharmacy services, catalyzed by the global shift towards digital health solutions, has expanded the reach of retail drugs, particularly in remote and underserved areas. Another critical driver is the technological advancement in pharmaceutical manufacturing and distribution, which has significantly enhanced the efficiency of drug production and delivery.
United States Pharmaceuticals Market Leaders
Similar to the opioid and cannabinoid market, the stimulant market is subject to change. Furthermore, domestic production is a key strategy to reduce drug prices as the biggest markups typically occur at the time of border-crossing . By reducing the risk that comes with the trading and smuggling of opioids over long distances and across multiple country borders, drug dealers are able to increase the availability of their product . In the US, the largest share of fentanyl is produced in and imported from Mexico, whereas repeated dismantling of drug laboratories in Canada suggest regionalised production within country borders 28–30. Novel synthetic opioids like nitazenes are also the subject of rapid structural development and challenge forensic chemists in their efforts to keep up with toxicological profiling and characterisation .
The oral route is the most preferred route of administration due to its ease of use and cost-effectiveness. At present, around 620 million people worldwide are living with heart and circulatory diseases, and it is estimated that around 60 million new cases of cardiovascular diseases are reported annually. Cardiovascular disorders are a major public health concern for individuals globally. Increased funding facilitates market entry strategies, such as conducting market assessments, obtaining necessary licenses, and adapting products to meet specific regional requirements.
One such individual, Eldi Dizdari was accused of international drug trafficking and was living in Dubai. The UAE is amongst the enablers of global corruption and illicit financial flows. Within the network of these groups, the dealmakers operate near supply sources and the distribution networks are managed by foot soldiers. These groups have moved up from being small-time crooks to major drug distributors. These prisons were under-regulated, under-funded, and under-staffed, which allowed for the formation of prison gangs, for the smuggling of arms/weapons/etc., for feasible escapes, and even for captured drug lords to continue running their businesses from prison.
This trend is exemplified by the fact that carfentanil is now being found more frequently than heroin during drug seizures . According to Canadian drug seizure statistics heroin is no longer among the top ten recovered illegal substances 32, 40. Strong prescription control was then put in place, but without an expansion of pain and addiction treatment . In the coroner’s report from BC, this translated to a steep incline in the presence of benzodiazepines in drug toxicity deaths, with etizolam being involved in 35% of deaths that underwent expedited toxicological testing . However, with heroin becoming rare on North American street markets, the practice shifted towards the combination of fentanyl with benzodiazepines. The prevalence of stimulant use is increasing, and novel synthetic stimulants enter the market each year.
Data Availability
Fentanyl has saturated many U.S. drug markets as a cheaper and more potent replacement for heroin, and entered others where heroin was rare or absent. Even the emergence and decline of specific drugs has little effect; deadly as fentanyl is, statistically, it looks merely like an extension of what was even in 2015 a 35-year trend. Four decades of unabated growth in drug-related fatalities in the United States shows an escalating public health crisis, though drug use prevalence has not shown much increase since 2002. The World Drug Report 2025 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also at assisting Member States in anticipating and addressing threats posed by drug markets and mitigating their consequences.
For instance, Abiraterone used in the treatment of prostate cancer can cost the patient USD 10,000 per month at its lowest and not even cure the disease. This has led to increasing demand from patients due to their unmet clinical needs and demand for positive clinical outcomes. This is primarily attributed to the fact that in the global scenario, there has been an increasing prevalence of several chronic disorders.
Generic pharmaceuticals undergo testing for quality, strength, purity, and potency to show effectiveness before being approved. They require approval by the respective regulatory agencies to be marketed in that particular country. Each bar represents total savings, with a breakdown of "first generic" savings highlighted in a darker shade. AI can also be used to determine the crystal structure of the drug compound. AI can enable researchers to optimize drug design, develop formulations, and streamline clinical trials more accurately and efficiently.
Drugs are substances other than food, derived from natural, synthetic, or semisynthetic sources, containing active pharmaceutical ingredients (API) and excipients, to achieve their pharmacological activity in the body. North America dominated this market in 2024, by majorly impacting factors like the adoption of technological advancements like targeted therapies and biologics with personalized medicine as well. The Brookings Institution is a nonprofit organization based in Washington, D.C. Our mission is to conduct in-depth, nonpartisan research to improve policy and governance at local, national, and global levels. Expanding treatment and harm reduction services in quality, quantity, and accessibility is perhaps all that can be done at this stage to reduce the devastating drug death rates in the United States.
